May 11-14, 2026
Hynes Convention CenterBoston, MADr. Pablo Lores Lareo, PhDCMC Director at SylentisSpeaker
Profile
CMC Director at Sylentis, a leading CDMO specializing in the development and manufacturing of therapeutic oligonucleotides. I bring extensive experience in analytical development, GMP manufacturing, and regulatory strategy for innovative oligonucleotide-based therapies.
Agenda Sessions
Manufacturing Aspects of an IND
, 2:25pmView SessionPanel Discussion and Ask the Consultants
, 4:15pmView Session